Search

everythinglearnresearchcommunity

for

Search:↓

AR gene not major factor in female hair loss; different from male hair loss.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

EF and PXE not closely related.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Evening primrose oil significantly improves hormone levels and reduces BMI and cholesterol in women with PCOS.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Nanog gene boosts stem cells, helps hair growth, and may treat hair loss.

The article concludes that proper antifungal treatment is essential for treating scalp fungal infections in children, and trichoscopy is useful for diagnosis and monitoring.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

Panax ginseng is generally safe with mild side effects and may have health benefits, but more research is needed.

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

Low iron and vitamin D levels are linked to hair loss in women.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.